FDA committee votes against Eli Lilly cancer treatment over concerns trials conducted only in China

Previous article

Dow drops 500 points, Nasdaq sinks more than 2% on fears of a Russian attack on Ukraine

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Stock News